Sign in

You're signed outSign in or to get full access.

VR Adviser, LLC

CIK:0001615982
Investment Adviser
$3B AUM
31 holdings
New York, NY, United States
Founded:2014
11 employees
Latest filing:Jun 30, 2025

VR Adviser, LLC is an investment advisory firm based in New York, NY, and is affiliated with Venrock, a well-known venture capital and investment management platform. The firm was founded in 2014 and primarily serves pooled investment vehicles, focusing on long-term investment opportunities in small capitalization public companies. As of 2025, the firm manages several investment funds and employs 11 people, with all employees serving as investment professionals.

Investment Strategy

VR Adviser, LLC acts as an adviser to pooled investment vehicles with a core strategy of identifying long-term investment opportunities in small capitalization public companies, typically within the healthcare and life sciences sectors. The firm takes a research-driven approach, leveraging deep industry expertise to invest primarily in innovative and high-growth companies, often with a focus on the therapeutic development and biotechnology markets.

Latest 13F Filing Activity

VR Adviser, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 31 equity positions with a total 13F market value of $1B. The fund increased holdings in Apogee Therapeutics Inc., Oric Pharmaceuticals Inc., Jade Biosciences Inc. among other positions. VR Adviser, LLC reduced exposure to Praxis Precision Medicines I, Dianthus Therapeutics Inc., Pharvaris N V among others.

Top Buys
A
APGEAPOGEE THERAPEUTICS INC
+$51.6M
O
ORICORIC PHARMACEUTICALS INC
+$49.2M
J
JBIOJADE BIOSCIENCES INC
+$32.2M
C
CTMXCYTOMX THERAPEUTICS INC
+$31.7M
O
OCULOCULAR THERAPEUTIX INC
+$24.9M
Top Sells
P
PRAXPRAXIS PRECISION MEDICINES I
-$37.5M
D
DNTHDIANTHUS THERAPEUTICS INC
-$13.0M
P
PHVSPHARVARIS N V
-$12.8M
S
SLDBSOLID BIOSCIENCES INC
-$9.2M
E
ENGNENGENE HOLDINGS INC
-$4.2M

Top Holdings

A
APGEAPOGEE THERAPEUTICS INC
+27.6%$368.9M
O
OCULOCULAR THERAPEUTIX INC
+8.9%$118.4M
M
MTSRMETSERA INC
+8.0%$106.7M
E
ELVNENLIVEN THERAPEUTICS INC
+6.1%$80.8M
K
KALVKALVISTA PHARMACEUTICALS INC
+5.7%$76.1M

Equity Positions (31)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
APOGEE THERAPEUTICS INC27.64%$368.9M8,493,321$21.30$43.43+$51.6M
OCULAR THERAPEUTIX INC8.88%$118.4M12,762,462$6.11$9.28+$24.9M
METSERA INC8.00%$106.7M3,750,662$27.22$28.45+$4.6M
ENLIVEN THERAPEUTICS INC6.05%$80.8M4,026,331$19.61$20.06+$1.5M
KALVISTA PHARMACEUTICALS INC5.70%$76.1M6,728,985$9.55$11.31-$1.3M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+58.2%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+31.6%
SERVICES-MEDICAL LABORATORIES
+4.7%
BLANK CHECKS
+0.4%

Investment Team (16)

NameRoleLocationLinkedIn
Bob Kocher
Bob Kocher
PartnerPalo Alto, CA , United States
Brian Ascher
Brian Ascher
PartnerMenlo Park, CA , United States
Ethan Batraski
Ethan Batraski
PartnerCA , United States
Ken Greenberg
Ken Greenberg
PartnerNew York, NY , United States
Lesley Kelly
Lesley Kelly
Head TraderNew York, NY , United States
L
Lisa Harris
PartnerRedmond, WA , United States
Mike Tyrrell
Mike Tyrrell
General PartnerCambridge, MA , United States
Nick Beim
Nick Beim
PartnerNew York, NY , United States
Andrew Gottesdiener
Andrew Gottesdiener
PartnerNew York, NY , United States
A
Anthony Evnin
partnerNew York, NY , United States
Showing 1-10 of 16 team members